ChartMill assigns a Buy % Consensus number of 76% to OTLK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-09-22 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-08-29 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-08-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-08-28 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-08-15 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-02-24 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-02-18 | Chardan Capital | Maintains | Neutral -> Neutral |
| 2025-02-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-17 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-02 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2024-11-29 | BTIG | Maintains | Buy -> Buy |
| 2024-11-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-18 | BTIG | Reiterate | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-27 | BTIG | Upgrade | Neutral -> Buy |
| 2024-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-15 | Chardan Capital | Upgrade | Neutral -> Buy |
| 2024-01-25 | Brookline Capital | Upgrade | Hold -> Buy |
| 2024-01-25 | Guggenheim | Upgrade | Neutral -> Buy |
| 2023-12-29 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-12-27 | Capital One | Upgrade | Equal-Weight -> Overweight |
| 2023-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-31 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2023-08-31 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
11 analysts have analysed OTLK and the average price target is 9.59 USD. This implies a price increase of 435.64% is expected in the next year compared to the current price of 1.79.
The consensus rating for OUTLOOK THERAPEUTICS INC (OTLK) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.